A smoking-cessation program consisting of extensive counseling, pharmacotherapy, and office spirometry: Results of a pilot project in a veterans administration medical center

被引:6
作者
Kennedy, DT
Paulson, DM
Eddy, TD
Patel, PC
Patkar, AD
Holdford, DA
Genina, VY
Griffin, EN
机构
[1] Sanofi Synthelabo Inc, Med Affairs, Dept Med Therapeut, New York, NY USA
[2] Sanofi Synthelabo Inc, US Clin Res Unit, New York, NY USA
[3] Hunter Holmes McGuire Vet Adm Med Ctr, Richmond, VA USA
[4] Virginia Commonwealth Univ, Sch Pharm, Richmond, VA USA
来源
PHARMACOTHERAPY | 2004年 / 24卷 / 10期
关键词
smoking cessation; spirometry; veterans administration; VAMC;
D O I
10.1592/phco.24.14.1400.43153
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objective. To describe the 1-year outcomes of a Veterans Administration smoking-cessation program that demonstrates a standard of care comprising extensive counseling, pharmacotherapy, and office spirometry Design. Prospective one-group pretest-posttest, with an intervention of state-of-the-art practice in smoking cessation. Setting. Outpatient clinic in a Veterans Administration Medical Center (VAMC). Patients. Two hundred fifty-two veterans receiving health care at the VAMC. Measurements and Main Results. The primary outcome measured was the 1-year cessation rate of smokers. Demographic and clinical covariates also were collected. Of the 252 patients who enrolled in the program, 120 never quit smoking for even 1 day. Of the remaining 132 patients, 32 (24%) achieved long-term (1 yr) cessation. The number of visits to the clinic and the number of methods used during the attempt to quit were the only variables significantly associated with long-term smoking cessation (p<0.0001 for each). Conclusion. The availability of a standard-of-practice clinic for smoking cessation within a primary care clinic can help patients who have a desire to quit. A combination of intensive counseling, pharmacotherapy, and office spirometry helped patients in a Veterans Administration population to achieve long-term smoking cessation.
引用
收藏
页码:1400 / 1407
页数:8
相关论文
共 25 条
[1]  
*AM LUNG ASS EP ST, TRENDS TOB US
[2]   EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].
ANTHONISEN, NR ;
CONNETT, JE ;
KILEY, JP ;
ALTOSE, MD ;
BAILEY, WC ;
BUIST, AS ;
CONWAY, WA ;
ENRIGHT, PL ;
KANNER, RE ;
OHARA, P ;
OWENS, GR ;
SCANLON, PD ;
TASHKIN, DP ;
WISE, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505
[3]  
*CDCP, 1999, MMWR-MORBID MORTAL W, V48, P993
[4]   Transdermal nicotine therapy and primary care - Importance of counseling, demographic, and participant selection factors on 1-year quit rates [J].
Daughton, D ;
Susman, J ;
Sitorius, M ;
Belenky, S ;
Millatmal, T ;
Nowak, R ;
Patil, K ;
Rennard, SI .
ARCHIVES OF FAMILY MEDICINE, 1998, 7 (05) :425-430
[5]   Office spirometry for lung health assessment in adults - A consensus statement from the National Lung Health Education Program [J].
Ferguson, GT ;
Enright, PL ;
Buist, AS ;
Higgins, MW .
CHEST, 2000, 117 (04) :1146-1161
[6]  
FIORE MC, 2000, QUICK REFERENCE GUID
[7]   Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler [J].
Hajek, P ;
West, R ;
Foulds, J ;
Nilsson, F ;
Burrows, S ;
Meadow, A .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (17) :2033-2038
[8]  
HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119
[9]   Reviews of evidence regarding interventions to reduce tobacco use and exposure ao environmental tobacco smoke [J].
Hopkins, DP ;
Briss, PA ;
Ricard, CJ ;
Husten, CG ;
Carande-Rulis, VG ;
Fielding, JE ;
Alao, MO ;
McKenna, JW ;
Sharp, DJ ;
Harris, JR ;
Woollery, TA ;
Harris, KW .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2001, 20 (02) :16-66
[10]   Recent advances in the pharmacotherapy of smoking [J].
Hughes, JR ;
Goldstein, MG ;
Hurt, RD ;
Shiffman, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (01) :72-76